Therapeutic Drug Monitoring And Pharmacogenetics to Tune Imatinib Exposure In Gastrointestinal Stromal Tumor Patients: Hurdles and Perspectives for Clinical Implementation

Tweetable abstract Present evidence supports the use of intensified pharmacologic monitoring of #imatinib including #TherapeuticDrugMonitoring and #PGx to improve outcomes in patients with GI stromal tumor. Future studies need to address emerging questions to facilitate implementation in clinics.